Bone Biologics (BBLG) Interest Coverage Ratio (QoQ) (2014 - 2025)
Powered by 
Analysis
Bone Biologics (BBLG) Interest Coverage Ratio (QoQ) (2014 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Bone Biologics | 1.00 Mn | 1.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -181.13% |
| Dec 31, 2024 | -447.01% |
| Dec 31, 2021 | -3,696.19% |
| Sep 30, 2021 | 7.81% |
| Jun 30, 2021 | -23.63% |
| Mar 31, 2021 | 13.59% |
| Dec 31, 2020 | -42.11% |
| Sep 30, 2020 | -9.48% |
| Jun 30, 2020 | 59.72% |
| Mar 31, 2020 | -21.67% |
| Dec 31, 2019 | 5.49% |
| Sep 30, 2019 | 58.26% |
| Jun 30, 2019 | 49.24% |
| Mar 31, 2019 | -2.31% |
| Dec 31, 2018 | -414.58% |
| Sep 30, 2018 | 179.33% |
| Jun 30, 2018 | 30.10% |
| Mar 31, 2018 | -241.11% |
| Dec 31, 2017 | 1.10% |
| Sep 30, 2017 | -144.02% |